ZOETIS INC (ZOE.DE) Stock Price, Forecast & Analysis
Europe • Frankfurt Stock Exchange • FRA:ZOE • US98978V1035
ZOE.DE Key Statistics, Chart & Performance
The current stock price of ZOE.DE is 105.12 EUR. In the past month the price decreased by -2.9%. In the past year, price decreased by -37.17%.
ZOE.DE Technical Analysis
ZOE.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ZOE.DE. Both the health and profitability get an excellent rating, making ZOE.DE a very profitable company, without any liquidiy or solvency issues.
ZOE.DE Financial Highlights
Over the last trailing twelve months ZOE.DE reported a non-GAAP Earnings per Share(EPS) of 5.32. The EPS increased by 10.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.21% | ||
| ROA | 17.49% | ||
| ROE | 49.11% | ||
| Debt/Equity | 1.31 |
ZOE.DE Forecast & Estimates
24 analysts have analysed ZOE.DE and the average price target is 140.97 EUR. This implies a price increase of 34.1% is expected in the next year compared to the current price of 105.12.
For the next year, analysts expect an EPS growth of 8.17% and a revenue growth 2.07% for ZOE.DE
ZOE.DE Ownership
About ZOE.DE
Company Profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company Info
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY US
Employees: 13800
Phone: 19738227000
ZOETIS INC / ZOE.DE FAQ
What does ZOE do?
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
What is the current price of ZOE stock?
The current stock price of ZOE.DE is 105.12 EUR. The price increased by 2% in the last trading session.
Does ZOE stock pay dividends?
ZOETIS INC (ZOE.DE) has a dividend yield of 1.64%. The yearly dividend amount is currently 1.45.
How is the ChartMill rating for ZOETIS INC?
ZOE.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the sector and industry classification for ZOETIS INC?
ZOETIS INC (ZOE.DE) operates in the Health Care sector and the Pharmaceuticals industry.
What is the expected growth for ZOE stock?
The Revenue of ZOETIS INC (ZOE.DE) is expected to grow by 2.07% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for ZOETIS INC?
ZOETIS INC (ZOE.DE) currently has 13800 employees.